Dr Reddy’s denied permission to conduct phase 3 trials of Russia’s Sputnik Light vaccine in India: Report
Indian drug regulatory body has reportedly denied permission to conduct the phase 3 trials of the Russian Covid-19 vaccine- Sputnik Light- in the country.
Jul 01, 2021, 11:30 AM IST
COVID-19: Commercial launch of Sputnik V vaccine may be deferred, says Dr Reddy's
Dr Reddy's said that the commercial launch of the Russian COVID-19 vaccine may be postponed due to dependency on imported consignments and quality testing.
Jun 29, 2021, 12:22 PM IST
Dr Reddy’s fixes price of DRDO’s 2-DG anti-COVID drug at Rs 990 per sachet
DRDO's anti-COVID-19 drug 2-DG will be supplied to government hospitals, the central and state governments at a discounted price.
May 28, 2021, 14:52 PM IST
DRDO’s anti-COVID-19 drug 2-DG likely to be available by mid-June: Dr Reddy's
In a statement, Hyderabad based Dr Reddy's clarified that 2-DG is not yet available in the market and the commercial launch of the drug is expected by mid-June.
May 20, 2021, 07:41 AM IST
Russia’s Sputnik V COVID-19 vaccine to be available in India soon, know price and other details
Russia's Sputnik V vaccine will be available in India in collaboration with Dr. Reddy’s Lab. A dose of imported Sputnik 5V vaccine in India will be priced at Rs 995 including 5 percent GST.
May 14, 2021, 15:16 PM IST
Sensex jumps for 2nd day, up 276 points; Infosys shapes up
Revival of buying interest in the recently battered Infosys, banking and financial stocks drove the market higher.
Aug 23, 2017, 16:51 PM IST
634 drugs on NPPA's price ceiling non-compliant list
As many as 634 drugs of various strengths produced by firms, including Cipla, Abbott, Astrazeneca and Dr Reddy's, are "suspected" to be non-compliant with ceiling prices as notified by NPPA.
Feb 23, 2017, 23:33 PM IST
Dr Reddy's board approves share buyback for Rs 1,569.4 crore
Drug major Dr Reddy's will buyback around 44.85 lakh shares, accounting for about 2.6 percent of the existing paid up capital of the company, for up to Rs 1,569.4 crore.
Feb 17, 2016, 21:12 PM IST
Antim Baazi: Sun Pharma & Dr Reddys
Check out our expert's advice on Sun Pharma and Dr Reddys.
Nov 26, 2015, 20:07 PM IST
USFDA gives Dr Reddy's addl time to respond to warning letter
Dr Reddy's Laboratories Ltd (DRL) Thursday said the USFDA has extended the time-frame for replying to the warning letter issued to the company by about two weeks to December 7.
Nov 26, 2015, 18:38 PM IST
Dr Reddy's buys IPR for anti-coagulant drug for $17.5 mn
The company had earlier inked a term sheet for this transaction in September.
Nov 18, 2015, 16:25 PM IST
Dr Reddy's Lab Q2 net profit rises 26% to Rs 722 crore
Aided by good sales growth coupled with new product launches, drug major Dr Reddy's Laboratories Thursday reported a 25.74 percent jump in consolidated net profit at Rs 721.89 crore for the second quarter ended September 30.
Oct 29, 2015, 20:30 PM IST
Dr Reddy's to market three Amgen drugs in India
Dr Reddy's Laboratories on Thursday said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs used to treat heart diseases and cancer in India.
Aug 06, 2015, 12:57 PM IST
Dr Reddy's launches hair growth supplement
The supplement provides key nutrients needed for maintaining healthy hair and according to the company, has a unique formula including grape seed extract containing potent antioxidants.
Jun 19, 2015, 21:08 PM IST
Dr Reddy's Lab to enter Japanese market through a partner
Pharmaceutical major Dr Reddy's Laboratories Tuesday said it has plans to enter Japanese market through partnerships for specific products.
May 12, 2015, 19:37 PM IST
Dr Reddy's Q4 net rises 8% to Rs 519 crore
The company had posted a net profit of Rs 481.60 crore for the corresponding period of previous fiscal, it said in a filing to the BSE.
May 12, 2015, 16:02 PM IST
Dr Reddy's to launch Hepatitis C drug in India
Dr Reddy's Laboratories today entered into an agreement with Hetero to distribute and market generic version of US-firm Gilead Sciences' Hepatitis C drug under the brand 'Resof' in India.
Mar 23, 2015, 17:50 PM IST
Dr Reddy's acquires Habitrol brand
City-based drugmaker Dr Reddy's Laboratories has acquired Habitrol brand, a nicotine replacement therapy transdermal patch, from Novartis Consumer Health Inc.
Dec 19, 2014, 16:02 PM IST
Dr Reddy's plant gets USFDA fiat on suspected lapses
The company is in the process of responding to the FDA's observations, a Dr Reddy's spokesperson said.
Nov 26, 2014, 19:44 PM IST
Dr Reddy's launches Docetaxel injection in US
Dr Reddy's Laboratories has launched Docetaxel injection USP 20 mg/mL and 80 mg/4 mL, a generic version of Taxotere (docetaxel injection) in the US market.
Nov 24, 2014, 13:49 PM IST
